Editor of Patient Care Online.
Daily Dose: Acupuncture for Irritable Bowel Syndrome
Your daily dose of clinical news you may have missed.
Mediterranean Diet Associated with Lower Risk of Adverse Pregnancy Outcomes, Suggests New Study
Findings showed that greater concordance to the Mediterranean diet was linked to a 21% lower risk of developing any adverse pregnancy outcomes.
Speculation Continues on Cause of Damar Hamlin’s On-field Cardiac Arrest
Commotio cordis is among the theories circulating around Buffalo Bills safety Damar Hamlin's on-field cardiac arrest.
Waning Protection from Pfizer-BioNTech COVID-19 Vaccine at 3 Months in Children is Restored, Sustained for 3 Months by Monovalent Booster
A new study points to the Pfizer shot's initially limited protection against the COVID-19 Omicron variant in those aged 5-11 years and also the the value of vaccine boosters.
FDA Approves Novel Capsid Inhibitor for Super-Refractory HIV-1 Infection
Lenacapavir is the first of a new class of antiretrovirals, and it is indicated for persons with multidrug resistance, intolerance, or safety considerations.
Daily Dose: Variable BMI Pattern May Serve as Indicator for Dementia
Daily Dose: Bivalent Boosters Protect Against Severe COVID-19 Disease
Topline Data Suggests Novel Pain Therapy Cebranopadol Has Significantly Less Potential for Abuse Compared to Tramadol, Oxycodone
Data from a phase 1 study of nondependent recreational opioid users suggests cebranopadol has a lower potential for abuse compared to C-II and C-IV opioids
Daily Dose: Concomitant Gestational Diabetes, Hypertensive Disorder Raise Long-term Postpartum CVD Risk
5 New Drugs Approved for Primary Care: Q4 2022
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
Daily Dose: Statin Treatment, Duration Linked to Reduced Risk of Hemorrhagic Stroke
Daily Dose: Pediatric Obesity Treatment
FDA Grants Priority Review to Pfizer’s RSV Vaccine Candidate for Older Americans
The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for adults aged ≥60 years.
Respiratory Virus Season Update: By the Numbers
Drug Overdose Deaths Reach Record High among Pregnant, Postpartum Women in US
Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.
Daily Dose: Statin Prescribing in Primary Care
Daily Dose: Morning Exercise Reduces Risk for Cardiovascular Disease
Pfizer-BioNTech Seek EUA for Omicron Booster in Children Aged Under 5 Years
Pfizer and BioNTech submitted an application to the FDA for emergency use authorization of their omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.
Daily Dose: Top Factors that Predict Long COVID
Morning Exercise Reduces Risk for Cardiovascular Disease in a New Study of UK Adults
Being most physically active in the late morning had a 16% decreased risk of coronary artery disease and a 17% decreased risk of stroke compared to midday.
Daily Dose: ASCVD Risk Reduced by 10% with Diet
Adults with and Without COVID-19 Report Similar Negative Effects on Wellbeing 3 Months After Illness
Pandemic-related stress and depression may be slowing recovery from long COVID-19 and other illnesses, according to researchers.
Daily Dose: Benzodiazepines for Sleep Disorders Linked to Increased Risk for Drug Overdose among Youth
Daily Dose: US Preterm Birth Rate Reaches 15-year High
Benzodiazepines for Sleep Disorders Linked to Increased Risk for Drug Overdose among Youth
New findings suggest that the elevated risk of overdose with benzodiazepine use for sleep disorders is a critical safety consideration when treating young people.
Daily Dose: Parent-Pediatrician Vaccine Discussions Lagging?
Spinal Cord Stimulators for Chronic Pain May do More Harm than Good, Suggests Real-world Study
Large study comparing spinal cord stimulators to conventional medical management found a lack of clinical benefit for most patients and possible harm to some.
Daily Dose: HDL Cholesterol May No Longer be So "Good"
Daily Dose: High-risk Patients with Atrial Fibrillation Not Prescribed Anticoagulation
Study: Wearable Activity Trackers Have Potential to Support Decision Making, Clinical Care
Wearable activity trackers could potentially support clinical care for patients with pulmonary arterial hypertension, according to a new study.